Doctor Clare Proudfoot
Novartis Pharma AG, Basel (Switzerland)
Patients with heart failure and a LVEF less than 40% present an overall lower health related quality of life than those with LVEF between 40% and 60%: a multinational real-world survey in EU
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic Heart Failure ePosters
ESC 365 is supported by
